ENTPD1 and cancer: The expression of ICs, PD-1 and TIGIT, and of CD39 as well as that of activation and proliferation markers in a population found at higher proportions in cancer patients than in HDs suggested that it could encompass exhausted tumor-Ag-specific T cells.